Elevated circulating ghrelin, but not peptide YY(3-36) levels, in term neonates with infection. 2015

Tania Siahanidou, and Alexandra Margeli, and Chrysanthi Tsirogianni, and Eugenia Hantzi, and Ioannis Papassotiriou, and George Chrousos

BACKGROUND Early diagnosis and treatment of neonatal infection is important to prevent morbidity and mortality. The gastrointestinal tract-derived hormones ghrelin and peptide YY (PYY), which participate in the regulation of food intake and energy balance, may also play roles in the inflammatory response. Their involvement in neonatal infection is not known. METHODS Plasma ghrelin and PYY(3-36) levels were serially measured (by ELISA) on Days 0, 1, 2, 3 and 7 following admission in 36-term neonates with febrile infection (22 of them were septic) and once in 20 healthy term neonates of similar postnatal age and gender distribution, as controls. Associations of ghrelin and PYY(3-36) levels with clinical and laboratory parameters, including anthropometrics, fever, leukocyte and platelet counts, serum glucose, C-reactive protein (CRP) and serum amyloid A levels, were assessed. RESULTS Plasma ghrelin levels were significantly higher in infected neonates than in controls at each study day (p=0.009), whereas PYY(3-36) levels did not differ significantly between patients and controls at any day. In infected neonates, ghrelin levels on admission correlated negatively with serum glucose levels (p=0.003), whereas fever change during the course of infection was significantly associated with change of ghrelin levels (p=0.01). Receiver operating characteristic analysis of ghrelin levels resulted in significant areas under the curve (AUC) for detecting infected neonates on admission (AUC=0.728, p=0.005). CONCLUSIONS Circulating ghrelin, but not PYY(3-36), levels are increased in neonates with infection, possibly reflecting and/or participating in the inflammatory process.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D007239 Infections Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases. Infection,Infection and Infestation,Infections and Infestations,Infestation and Infection,Infestations and Infections
D008297 Male Males
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune

Related Publications

Tania Siahanidou, and Alexandra Margeli, and Chrysanthi Tsirogianni, and Eugenia Hantzi, and Ioannis Papassotiriou, and George Chrousos
November 2004, Endocrinology,
Tania Siahanidou, and Alexandra Margeli, and Chrysanthi Tsirogianni, and Eugenia Hantzi, and Ioannis Papassotiriou, and George Chrousos
September 2011, Nutrition (Burbank, Los Angeles County, Calif.),
Tania Siahanidou, and Alexandra Margeli, and Chrysanthi Tsirogianni, and Eugenia Hantzi, and Ioannis Papassotiriou, and George Chrousos
May 2006, Obesity surgery,
Tania Siahanidou, and Alexandra Margeli, and Chrysanthi Tsirogianni, and Eugenia Hantzi, and Ioannis Papassotiriou, and George Chrousos
December 1986, Pediatric research,
Tania Siahanidou, and Alexandra Margeli, and Chrysanthi Tsirogianni, and Eugenia Hantzi, and Ioannis Papassotiriou, and George Chrousos
February 2007, The Journal of clinical endocrinology and metabolism,
Tania Siahanidou, and Alexandra Margeli, and Chrysanthi Tsirogianni, and Eugenia Hantzi, and Ioannis Papassotiriou, and George Chrousos
November 2005, Diabetes,
Tania Siahanidou, and Alexandra Margeli, and Chrysanthi Tsirogianni, and Eugenia Hantzi, and Ioannis Papassotiriou, and George Chrousos
July 2004, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
Tania Siahanidou, and Alexandra Margeli, and Chrysanthi Tsirogianni, and Eugenia Hantzi, and Ioannis Papassotiriou, and George Chrousos
December 2006, Metabolism: clinical and experimental,
Tania Siahanidou, and Alexandra Margeli, and Chrysanthi Tsirogianni, and Eugenia Hantzi, and Ioannis Papassotiriou, and George Chrousos
June 2006, Obesity surgery,
Tania Siahanidou, and Alexandra Margeli, and Chrysanthi Tsirogianni, and Eugenia Hantzi, and Ioannis Papassotiriou, and George Chrousos
January 2006, Endocrinology,
Copied contents to your clipboard!